These positive effects in cognitive behavior are regulated by inhibiting Sp1 and its target genes APP and BACE1. Thus, we hypothesized that tolfenamic acid could inhibit Htt and, furthermore, attenuate motor and cognitive deficits in HD mice. This evidence concerns the gene APP and Huntington disease.